MYELOMA, MULTIPLE
Clinical trials for MYELOMA, MULTIPLE explained in plain language.
Never miss a new study
Get alerted when new MYELOMA, MULTIPLE trials appear
Sign up with your email to follow new studies for MYELOMA, MULTIPLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Drug attack on blood cancer tested for frail patients
Disease control OngoingThis study is testing a combination of four drugs (lenalidomide, ixazomib, dexamethasone, and daratumumab) for older adults or those too frail for a stem cell transplant who have newly diagnosed multiple myeloma. The goal is to see if adding more drugs during long-term 'maintenan…
Matched conditions: MYELOMA, MULTIPLE
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Gene therapy trial aims to train immune cells to hunt blood cancer
Disease control OngoingThis is an early-stage safety study testing a new type of cell therapy for adults with multiple myeloma that has not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack the cancer, and then i…
Matched conditions: MYELOMA, MULTIPLE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC